Lingohr Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$8.95M |
| 2 |
B2Gold
BTG
|
+$511K |
| 3 |
Methanex
MEOH
|
+$493K |
| 4 |
SM Energy
SM
|
+$484K |
| 5 |
Synchrony
SYF
|
+$479K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOO
Bombardier Recreational Products
DOO
|
+$551K |
| 2 |
United Natural Foods
UNFI
|
+$493K |
| 3 |
Organon & Co
OGN
|
+$491K |
| 4 |
Cardinal Health
CAH
|
+$488K |
| 5 |
Nu Skin
NUS
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.08% |
| 2 | Consumer Discretionary | 16.54% |
| 3 | Technology | 15.35% |
| 4 | Energy | 15.26% |
| 5 | Industrials | 12.01% |
Similar funds
Lingohr Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Lingohr Asset Management held 99 positions worth $37.6M, down 1.3% from $38.1M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Lingohr Asset Management deployed $9.85M of net new capital in Q2 2022, opening 17 new positions and adding to 2 existing holdings. Its largest new stake was Alphabet (Google) Class A: 76,000 shares worth $442K.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the most notable exit was Bombardier Recreational Products, an estimated $551K sold.
- Lingohr Asset Management's largest Q2 2022 buy was Alphabet (Google) Class A: 76,000 shares worth $442K.
- Lingohr Asset Management added most to Concentrix in Q2 2022, an estimated $90.3K increase.
- Lingohr Asset Management fully exited Bombardier Recreational Products in Q2 2022, selling an estimated $551K.
- Lingohr Asset Management's ten largest holdings make up 15% of its $37.6M portfolio in Q2 2022.
- Lingohr Asset Management opened 17 new positions and closed 14 in Q2 2022.
- Lingohr Asset Management's portfolio value fell 1.3% quarter-over-quarter to $37.6M.
Based on Lingohr Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.